BDSI secures $20M loan to advance drug application
July 08, 2013 at 12:10 PM EDT
Raleigh drug developer BioDelivery Sciences International (Nasdaq: BDSI) borrowed $20 million to help it push through the final development stages before filing an application for a drug that could bring peak annual sales of $250 million...